发明名称 INHIBITOR OF BRUTON'S TYROSINE KINASE
摘要 <P>PROBLEM TO BE SOLVED: To bring advantages on the therapy of patients having related diseases by inhibiting the activity of tyrosine kinase. <P>SOLUTION: There are provided: compounds that form covalent bonds with Bruton's tyrosine kinase (Btk); irreversible inhibitors of Btk; methods for the preparation of the compounds; pharmaceutical compositions that include the compounds; and also methods of using the Btk inhibitors, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012105681(A) 申请公布日期 2012.06.07
申请号 JP20120049524 申请日期 2012.03.06
申请人 PHARMACYCLICS INC 发明人 HONIGBERG LEE;VERNER ERIK;PAN ZHENGYING
分类号 C12N9/12;A61K31/519;A61P1/04;A61P1/16;A61P3/02;A61P3/10;A61P5/00;A61P7/06;A61P9/00;A61P13/10;A61P15/00;A61P17/00;A61P17/06;A61P17/14;A61P19/02;A61P21/04;A61P25/00;A61P29/00;A61P37/06;A61P43/00;C07D487/04 主分类号 C12N9/12
代理机构 代理人
主权项
地址